10x Insights
Loading account…
VLTO

Veralto

IndustrialsMedical InstrumentsS&P 500
Ticker VLTOWALTHAM, MAFiscal year ends DecemberBook value per share $12.51Diluted shares 247.5M

Veralto Corporation is a global provider of essential technology solutions that monitor, enhance, and protect critical resources worldwide. The company was incorporated in 2023 as an independent, publicly traded entity following its separation from Danaher Corporation on September 30, 2023, when Danaher distributed… From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-07-03
Sales & profitability
$5.50BFY2025
+6.0% year over year
Last 12 mo $5.70B
23.21%FY2025
−0.1 percentage points
Last 12 mo 22.74%
$940.00MFY2025
+12.8% year over year
Last 12 mo $988.00M
30.27%FY2025
−10.6 percentage points
Last 12 mo 31.90%
Cash & financing
$1.08BFY2025
+23.1% year over year
Last 12 mo $1.10B
$1.01BFY2025
+23.7% year over year
Last 12 mo $1.05B
0.86FY2025
Was 1.28× a year earlier
Last 12 mo 1.09
250.3MFY2025
+0.3% year over year
Last 12 mo 247.5M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Veralto does

In the company’s own words

Veralto Corporation is a global provider of essential technology solutions that monitor, enhance, and protect critical resources worldwide. The company was incorporated in 2023 as an independent, publicly traded entity following its separation from Danaher Corporation on September 30, 2023, when Danaher distributed all shares of Veralto to its stockholders on a one-for-three basis. Veralto operates through two primary segments: Water Quality and Product Quality & Innovation, generating approximately $5.5 billion in annual sales with a workforce of nearly 17,000 associates distributed across approximately 50 countries.

The Water Quality segment provides comprehensive water analytics and treatment solutions through globally recognized brands including Hach, Trojan Technologies, and ChemTreat. These offerings serve municipal utilities, industrial customers, and research applications, with Hach alone serving over 149,000 customers and helping ensure safe water for approximately 3.4 billion people daily. Trojan Technologies' systems support treatment of 15 trillion gallons of water annually, while ChemTreat's solutions helped customers conserve over 88 billion gallons of water in 2025.

The Product Quality & Innovation segment enables brand owners in consumer packaged goods, food and beverage, pharmaceutical, and industrial sectors through marking and coding, and packaging and color solutions. Leading brands include Videojet, Linx, Esko, X-Rite, and Pantone. The company serves a majority of the top 25 global consumer packaged goods brands and a majority of the top 20 pharmaceutical brands. Veralto's business model emphasizes recurring revenue, with approximately 61 percent of sales derived from consumables, spare parts, services, and software solutions.

Geographically, Veralto generated 48 percent of 2025 sales from North America, 23 percent from Western Europe, 2 percent from other developed markets, and 27 percent from high-growth markets. The company maintains approximately 60 principal facilities globally, including 21 in the United States and 39 internationally. Veralto's competitive advantages include strong brand recognition, an extensive installed base generating recurring consumables sales, deep customer relationships, and the Veralto Enterprise System, a business management philosophy emphasizing continuous improvement and operational excellence.

Company details
Sector
Industrials
Industry (SIC)
Medical Instruments
Headquarters
WALTHAM, MA
Fiscal year end
December
CIK
1967680
SIC
3825

Financial performance, year by year

Fiscal 2023–2025 · USD
$-569.60M$1.14B$2.85B$4.56B$6.27B202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Veralto — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

776
funds hold it
1 of 35
superinvestors hold it
$8.57B
held by funds, at market
40.0%
of shares held by funds
5
bond issues held by funds

Superinvestors in Veralto · what they did last quarter

Wallace WeitzINCREASED +93.8%
Weitz Investment Management
0.5%of 13F portfolio

Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.

Largest fund holders · Veralto’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.03%of fund net assets
VANGUARD 500 INDEX FUND
VOO · VANGUARD INDEX FUNDS
0.03%of fund net assets
VANGUARD MID-CAP INDEX FUND
VO · VANGUARD INDEX FUNDS
0.21%of fund net assets
First Trust Rising Dividend Achievers ETF
RDVY · First Trust Exchange-Traded Fund VI
1.64%of fund net assets
T. Rowe Price Capital Appreciation Fund
PRWCX · T. ROWE PRICE CAPITAL APPRECIATION FUND, INC.
0.51%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Veralto’s bonds, as funds hold them

Funds report holding 5 issues of Veralto’s debt, $614.08M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 5.33%, maturing 2026 to 2033.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Veralto and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Veralto's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Veralto's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.